MidWest Gloves & Gear announces new birdfeeders for kids
ST. LOUIS — MidWest Gloves & Gear has introduced a new licensed line of birdfeeders for kids, which feature Mickey Mouse and Princess motifs from Disney and Teenage Mutant Ninja Turtles and Dora themes from Nickelodeon.
The MidWest Birdfeeders feature durable, weather-resistant plastic construction; a clear seed chamber; bird perches on all sides; and a 1.5-lb birdseed capacity. Decorative stickers are included for customizing.
“We are very proud to be the exclusive Disney & Nickelodeon licensees for these great new products," Stephen Franke, president of MidWest Quality Gloves Inc., said. "And we are being rewarded by the retailer buyer interest and excitement for these exciting and fun birdfeeders for kids.”
The birdfeeders are available to ship beginning Fall 2014.
Sluggish mass-market trends dampen L’Oréal Paris’ Q1 results
PARIS — L’Oréal Paris has released first-quarter sales results, which were hampered, in part, by sluggish trends in North America’s mass-market channel during the first few months of the year.
Total group sales for the quarter were €5.64 billion, down 2.2% compared with the year-ago period. On a like-for-like basis, sales rose 3.5%.
The consumer products division, which was held back in North America by a high launch-related comparison base and a slowing market, posted sales of €2.76 billion, down 5.5% compared with the year-ago. On a like-for-like basis, sales rose 1.2%.
When breaking out sales by geographic zone, sales in North America dropped 5.6% and decreased 0.6% on a like-for-like basis during the quarter.
“As anticipated, the Consumer Products Division contracted in the first quarter, because of the high comparison base in the first quarter of 2013 and the flat mass-market trend at the start of this year. Advanced Hair Care by L’Oréal Paris and Fructis by Garnier are growing strongly and winning market share in hair, while L’Oréal Paris make-up is reinforcing its position thanks to the new Butterfly mascara,” the company stated.
Teva launches generic Lunesta in the U.S.
JERUSALEM — Teva Pharmaceutical Industries announced the launch of a generic equivalent to Lunesta (eszopiclone tablets) in 1-,2- and 3-mg form in the United States. The drug is used to treat insomnia.
Lunesta tablets, which are marketed by Sunovion Pharmaceuticals, had annual sales of $852 million in the United States as of December 2013, according to IMS data.